Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Available from, as of September 5, 2018: Large IV doses of methylene blue may produce nausea, vomiting, abdominal pain, precordial pain, dizziness, headache, profuse sweating, dyspnea, hypertension, and mental confusion
Injectable (subcutaneous) BPC-157 has higher bioavailability, meaning more of it enters the bloodstream to exert systemic effects, like healing a tendon
Owing to intrinsic limitations of network meta-analysis, we avoided to analyze the effects of these drugs in several subgroupse.g., as stratified by age or the presence of CV disease or type 2 diabetesto avoid type 1 error due to the many subgroup analyses
Kobori Y, Suzuki K, Iwahata T, et al
Masayasu Kojima Author profile: KAKEN Researcher Profile Masayasu Kojimas published ghrelin research is relevant to the pathway-focused background discussed in this article
US$ 22.79
US$ 24.77
US$ 22.85
US$ 26.67
US$ 25.37
